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Abstract
Background: Constipation is the most common gastrointestinal complaint all over the world and it is a risk factor
of colorectal cancer. In this study, the efficacy of aqueous leaf extract of Aloe ferox Mill. was studied against
loperamide-induced constipation in Wistar rats.
Methods: Constipation was induced by oral administration of loperamide (3 mg/kg body weight) while the
control rats received normal saline. The constipated rats were treated with 50, 100 and 200 mg/kg body weight/
day of the extract for 7 days during which the feeding characteristics, body weight, fecal properties and
gastrointestinal transit ratio were monitored.
Results: The extract improved intestinal motility, increased fecal volume and normalized body weight in the
constipated rats, which are indications of laxative property of the herb with the 200 mg/kg body weight of the
extract showing the best efficacy.
Conclusion: The effect of the extract compares favourably well with senokot, a standard laxative drug. These
findings have therefore, lent scientific credence to the folkloric use of the herb as a laxative agent by the people of
the Eastern Cape of South Africa.
Background
Constipation is a highly prevalent functional gastro-
intestinal disorder affecting 3-15% of the general popula-
tion [1,2]. In South Africa, 29% of the population,
consisting of both black and white suffer from constipa-
tion especially in the elderly [3]. The menace has a sub-
stantial impact on morbidity and quality of life [4],
which may be characterized by unexplained abdominal
pain, discomfort and bloating in association with altered
bowel habits [5].
The use of chemical drugs such as senna, correctol,
exlax, senokot and gaviscon is very common as a means
of treating constipation. Statistics have shown that 43%
of whites and 76.6% of blacks in South Africa indulge in
the use of laxatives, out of which 14.3% and 21.5%
respectively use more than one laxative at a time for the
treatment of constipation [3]. The use of these orthodox
drugs is however, limited due to their high cost and
undesirable side affects [6]. Consequently, majority of
the affected persons in South Africa rely on herbal
preparations for the treatment of the menace. For
instance, some plant extracts are known to exhibit anti-
spasmodic effects by stimulating water absorption in the
intestine [7]. Apart from being fast acting, cheap and
readily available, the users of medicinal plants for the
treatment of constipation also believe that they have
some control in their choice of medication [8].
Aloe ferox Mill. belongs to the family Asphodelaceae.
The plant is widely distributed in the Southern Cape,
Eastern Cape, Southern parts of KwaZulu Natal, the
Free State and Lesotho. It is an arborescent perennial
shrub with a single stem of 2-3 m in height. The plant
is crowned by a large rosette of numerous leaves which
are glaucous and oval-lanceolate. It is one of the widely
used medicinal plants in traditional medicine because of
its healing properties against many ailments [9]. For
example, extract from the plant has been reported to be
effective in the treatment of tooth abscesses [10], sexu-
ally transmitted infections [11], wound healing [12],
arthritis and rheumatism [13], conjunctivitis and eye ail-
ment [14] and as insect repellant [15]. The herb is also
used traditionally as laxative; however, there is little or
no scientific report to substantiate this claim. The
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laxative activity of the aqueous leaf extract of Aloe ferox
on loperamide-induced constipated rats and the effect
was compared with senokot, a standard laxative drug.
Methods
Drugs and chemicals
Loperamide hydrochloride, carmine and carboxymethyl-
cellulose were procured from Sigma Chemical Co., St
Louis, MO, USA while senokot was a product of Reckitt
Benckiser Pharmaceutical (Pty) Ltd, South Africa. All
other chemicals and reagents used were of analytical
grade.
Plant materials
Fresh mature whole leaves of Aloe ferox were collected
in Ntselamanzi Area of Nkonkobe Municipality in the
Eastern Cape Province of South Africa. The Plant was
authenticated by Prof DS Grierson; a botanist in the
Department of Botany, University of Fort Hare and a
voucher specimen (Wintola Med.2009/01) was prepared
and deposited in the University herbarium.
Preparation of aqueous extract
The leaves of A. ferox were thoroughly washed with dis-
tilled water, cut into thin slices and dried in the oven at
50°C for 24 h. The dried leaves were grinded into pow-
der and 100 g of the material was extracted by shaking
for 24 h in 1000 ml of distilled water on an orbital sha-
ker (SO1 orbital shaker, Stuart scientific, Stone U. K).
The extract obtained was filtered through Whatman No
1 (70 mm) filter paper and Freeze dried (Vir Tis bench-
top k, Vir Tis company Gardiner NY) to give a yield of
24.4 g. This was reconstituted in distilled water to give
the required doses of 50, 100 and 200 mg/kg body
weight for the experiment.
Animal used
Male albino rats (Rattus norvegicus) of Wistar strain
with a mean weight of 140 ± 3.67 g were obtained from
the experimental animal house of the Agricultural and
Rural Development Research Institute (ARDRI), Univer-
sity of Fort Hare, Alice. The animals were housed indivi-
dually in clean metabolic cages placed in a well
ventilated house with optimum condition (temperature
23 ± 1°C, photoperiod; 12 h natural light and 12 h dark;
humidity; 45-50%). They were acclimatized to the ani-
mal house condition for 7 days during which they were
allowed free access to commercial pelleted rat chow
(Pioneer Food (Pty) Ltd, Huguenot, South Africa) and
water. The cleaning of the cages was done on a daily
basis. All animal treatments were in accordance with
international ethical guidelines and the National Insti-
t u t eo fH e a l t hg u i d ec o n c e r n i n gt h ec a r ea n du s eo f
laboratory animals. The study was carried out following
the approval from the Ethical Committee of the Univer-
sity of Fort Hare on the use and care of animals.
Induction of constipation in the rats
Constipation was induced in the animals by oral admin-
istration of 1 ml loperamide (3 mg/kg body weight in
0.9% sodium chloride for 3 days) [16], while the control
rats were administered with the normal saline only. The
Passage of reduced, hard and dry fecal pellets indicated
constipation in the rats.
Experimental design
The rats were grouped into six of four rats each. The
animals in Group 1 (control) and Group 2 (constipated
control) were administered with distilled water. Groups
3, 4 and 5 comprised constipated rats given 50, 100 and
200 mg/kg body weight/day of A. ferox extract respec-
tively while Group 6 were constipated rats administered
with senokot. The administration was done using metal
oropharyngeal cannula. The water intake, feed intake
and body weight gain of all the rats were recorded dur-
ing experimental period and treatment continued for 7
days.
Total number, dry weight and water content of fecal
pellet
The excreted fecal pellets of individual rats were col-
lected everyday at 09:00 h throughout the duration of
the experiment. Total number, weight and water content
of the pellets were determined. The water content was
calculated as the difference between the wet and dry
weights of the pellet.
Gastrointestinal transit (GIT) ratio
GIT ratio was measured according to the method of
N a k a g u r ae ta l .[ 1 7 ] .O nt h e7 t hd a y ,1m lo fc a r m i n e
(3 g suspended in 50 ml of 0.5% carboxymethylcellulose)
was orally administered to the rats. One hour after
administering the marker, the animals were sacrificed
and the small intestines were quickly removed. The dis-
tance over which the carmine had travelled and the
total length of the small intestine were measured. The
GIT ratio was expressed as the percentage of the dis-
tance travelled by the carmine relative to the total
length of the small intestine.
Statistical analysis
Data were expressed as means ± SD of four replicates
and were subjected to one way analysis of variance
(ANOVA) followed by Duncan multiple range test to
determine significant differences in all the parameters.
Values were considered statistically significant at
p < 0.05.
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Loperamide significantly reduced the water intake, the
number, water content and the weight of the fecal pel-
lets (Table 1). This was an indication of the induction of
constipation in the rats. However, there was no signifi-
cant difference in feed intake between the control and
the constipated animals.
While water consumption decreased in the untreated
constipated rats, the administration of aqueous extract
of A. ferox significantly increased the water intake in
constipated rats (Table 2). Again, there was no signifi-
cant difference in the feed intake of all the animals.
Similarly, the extract significantly increased the number,
water content and weight of fecal pellets in the consti-
pated rats in a dosage-dependent manner. The body
weights of the constipated animals were also normalized
following the treatment with the extract.
Loperamide administration significantly reduced gas-
trointestinal motility in the untreated constipated rats
(Fig.1). The treatment with the extract, however,
increased the gastrointestinal movement in a dose
dependent manner which compared favourably well
with senokot, a standard constipation drug.
Discussion
The use of herbal remedies in the treatment of constipa-
tion is a common practice in many countries of the
world including South Africa [13,18]. The present study
has clearly demonstrated that aqueous extract of Aloe
ferox has laxative activity; which is comparable to seno-
kot, a standard laxative drug.
The use of loperamide as constipation inducer is well
documented. The drug inhibits intestinal water secretion
[19] and colonic peristalsis [20]. This inhibition extends
fecal evacuation time and delays intestinal luminal tran-
sit [21]. Loperamide-induced constipation is therefore
considered to be a model of spastic constipation [22].
The observed reduction in the number, weight and
water content of fecal pellets following the treatment
with the drug indicated induction of constipation in the
rats. Similar observation was reported by Shimotoyo-
dome et al. [23]. The reduction in the water consumed
by the constipated animals may also be due to the effect
of the drug which probably accounted for the reduction
in water content of the fecal pellets. However, the drug
did not prevent the animals from feeding adequately.
The administration of aqueous extract of A. ferox to
the constipated rats was effective in influencing
increased defecation frequency, fecal volume and moti-
lity of the colon. These are indications of the laxative
property of the plant extract. This may be due to the
presence of anthranoid glycosides derivatives of which
aloin is the main compound [24,25]. According to Izzo
et al. [26], aloin is metabolized by the colonic flora to
reactive aloe-emodin which is responsible for the purga-
tive activity. This compound possibly exerts its action by
disturbing the equilibrium between the absorption of
water from the intestinal lumen via an active sodium
transport [27] and the secretion of water into the lumen
by prostaglandin-dependent mechanism [28,29].
Although the feed intake did not differ among the
groups, the gain in body weight was higher in the
untreated constipated rats compared to the extract treated
groups. This may be due to the accumulation of fecal pel-
lets in their bodies, thus accounting for the extra weight.
This clearly indicates that the plant extract increased
intestinal secretion and motility in the constipated rats.
Similar observation was reported by Niwa et al. [30] where
dietary fiber was used for the treatment of morphine-
induced constipation in rats. Of particular interest is the
fact that the effect of the extract of A. ferox was dose
dependent in this study. The effect of the highest dosage
actually compared favourably well with senokot.
Table 1 Effect of loperamide on feed intake, water intake
and fecal properties of constipated rats
Parameters Normal Control Constipated rats
Feed intake 15.32 ± 1.12 17.05 ± 0.74 *
Water intake 19.00 ± 1.41 8.92 ± 0.68 **
Number of fecal pellet 64.67 ± 2.80 24.04 ± 0.94**
Water content of fecal pellet 1.52 ± 0.17 0.57 ± 0.10**
Weight of fecal pellet 6.38 ± 0.30 2.95 ± 0.09**
Data are mean ± SD values (n = 4); *not significantly different; ** significantly
different from normal control at P < 0.05
Table 2 Effect of aqueous extract of Aloe ferox on feed and water intake, body weight gain and fecal properties of
constipated rats
Parameters Normal control Constipated control Constipated + A. ferox (mg/kg body weight) Senokot
50 100 200
Feed intake 17.18 ± 1.36
a 19.23 ± 3.86
a 19.90 ± 1.61
a 20.54 ± 1.38
a 17.80 ± 1.60
a 19.97 ± 3.31
a
Water intake 19.62 ± 2.22
a 11.72 ± 2.47
b 16.57 ± 2.05
a 17.24 ± 0.17
a 19.79 ± 2.33
a 18.14 ± 0.61
a
Number of fecal Pellet 73.57 ± 4.39
a 38.20 ± 2.21
b 45.43 ± 1.90
c 57.57 ± 1.62
d 69.83 ± 4.49
a 63.00 ± 3.11
a
Water content of fecal pellet (ml) 1.40 ± 0.08
a 1.04 ± 0.09
b 1.75 ± 0.21
c 1.95 ± 0.11
c 2.25 ± 0.21
d 2.09 ± 0.06
d
Weight of fecal pellet (g) 7.14 ± 0.23
a 3.34 ± 0.38
b 5.72 ± 0.18
c 7.42 ± 0.33
a 8.10 ± 0.72
a 7.31 ± 0.25
a
Body weight gain (g) 15.30 ± 1.00
a 33.80 ± 1.00
b 14.20 ± 0.71
a 13.20 ± 2.16
a 12.50 ± 1.85
a 15.35 ± 1.21
a
Data are mean ± SD values (n = 4). Row values with different superscripts from the control are significantly different (P < 0.05)
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reflected the overall gastrointestinal motor activity. Mea-
suring colonic transit time is useful in constipation,
abdominal bloating and refractory irritable bowel syn-
drome. It also provides quantitative information about
colonic transit, enables the identification and characteriza-
tion of transit abnormalities and allows assessment of the
severity of the problem as well as the response to therapy
[31]. In this study, carmine was used as the marker used
to measure the colonic movement. The extract increased
intestinal motility which, in turn, enhanced colonic peri-
stalsis in the rats. The possible mechanism of the extract
in this process may be by enhancing the release of fluid
thereby increasing intestinal secretion. The laxative effect
of the extract could also be attributed to changes in the
intestinal motility, which produced an increase in intest-
inal transit and colonic movement [32]. Generally, the
effect of the treatment with the extract compared favour-
ably well to that of senokot. This is an indication that the
herb was effective in ameliorating bowel obstruction,
thereby enhancing easy movement in the intestine.
Conclusion
The present study revealed that oral administration of
aqueous extract of Aloe ferox exhibited laxative activity
in loperamide induced constipated rats. This suggests
the beneficial effects of the herb in improving intestinal
motility. It is, however, very important to note that the
extract at 100 and 200 mg/kg body weight showed bet-
ter laxative action than at 50 mg/kg body weight. The
effect of the extract compared favourably with senokot.
These findings have lent scientific support to the folklo-
ric use of A. ferox as a laxative agent.
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